PPP2R2C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Specific Mortality
Eric G. Bluemn(Virginia Mason Medical Center), Peter S. Nelson(Fred Hutch Cancer Center), Elahe A. Mostaghel(University of Washington), Carla Grandori(Precision for Medicine (United States)), Ilsa M. Coleman(Fred Hutch Cancer Center), Xiaotun Zhang(Virginia Mason Medical Center), Christopher R. Porter(Virginia Mason Medical Center), Ryan R. Gordon(Virginia Mason Medical Center), Brigham H. Mecham(Boston University), Daniel Lewinshtein(Virginia Mason Medical Center), Elysia Sophie Spencer(Communities In Schools of Orange County), James Annis(Rosetta Stone (United States))
Cited by 48
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
|New England Journal of Medicine|2016|1.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
|Cancer Research|2008|1.4k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k